AstraZeneca will present the quarterly figures for the most recent quarter – closing date June 30, 2022 – at the financial conference on July 29, 2022.
Estimates by 16 analysts average EPS at $0.783 per share. In the same quarter of the previous year, USD 0.450 per share was still on the books.
On average, 16 analysts expect sales to increase by 27.18 percent compared to the sales of USD 8.22 billion generated in the same quarter last year. According to this, the experts are assuming an average turnover of USD 10.45 billion for the past quarter.
Overall, 25 analysts are expecting average earnings of $3.31 per share for the current fiscal year, compared to $2.65 per share last year. 24 analysts set annual sales at an average of USD 43.25 billion. In the previous year there were still 37.42 billion USD in the books.
Editorial office finanzen.net
Leverage must be between 2 and 20
No data
Image sources: Michael Vi / Shutterstock.com
